## **Core Concept**
The question revolves around the concept of reducing toxicity associated with nitrogen mustard compounds, which are a class of alkylating agents used in chemotherapy. These compounds work by cross-linking DNA strands, thereby inhibiting DNA replication and ultimately leading to cell death. However, their use is associated with significant toxicity, including bone marrow suppression, gastrointestinal toxicity, and others.

## **Why the Correct Answer is Right**
The correct answer involves the use of **sodium thiosulfate**. Sodium thiosulfate acts by providing a non-toxic nucleophile that can react with the alkylating agent (nitrogen mustard), thereby neutralizing its ability to cross-link DNA in normal tissues. This mechanism effectively reduces the toxicity of nitrogen mustards without significantly affecting their antitumor activity when administered locally or through specific delivery methods.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while cysteine and other thiol compounds can react with alkylating agents, sodium thiosulfate is specifically noted for its clinical use in reducing toxicity.
- **Option B:** This option is incorrect as there is no commonly recognized agent by this name used for reducing nitrogen mustard toxicity.
- **Option C:** This option might seem plausible due to its pharmacological properties, but it is not specifically indicated for reducing nitrogen mustard toxicity.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **sodium thiosulfate** is used not only to reduce the systemic toxicity of certain chemotherapeutic agents like cisplatin but also to protect against the local tissue toxicity of alkylating agents. For instance, it can be used to prevent or mitigate severe local tissue damage in cases of accidental extravasation of these drugs during administration.

## **Correct Answer:** . Sodium thiosulfate